Volume 64, Issue 6, Pages (December 2003)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Volume 63, Issue 1, Pages (January 2003)
Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms  Karen A. Griffin, Maria Picken, Anita.
Volume 70, Issue 4, Pages (August 2006)
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Ruisheng Liu, Oscar A. Carretero, Yilin Ren, Jeffrey L. Garvin 
Volume 61, Issue 2, Pages (February 2002)
Volume 57, Issue 2, Pages (October 2000)
Volume 61, Issue 2, (February 2002)
Volume 69, Issue 10, Pages (May 2006)
Volume 56, Pages S31-S36 (July 1999)
Volume 65, Issue 1, Pages (January 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 55, Issue 5, Pages (May 1999)
Progression of renal failure and hypertensive nephrosclerosis
Volume 58, Issue 6, Pages (December 2000)
Karen A. Griffin, Maria M. Picken, George L. Bakris, Anil K. Bidani 
Volume 70, Issue 7, Pages (October 2006)
Volume 68, Issue 3, Pages (September 2005)
Volume 59, Issue 4, Pages (April 2001)
Volume 54, Issue 6, Pages (January 1998)
Volume 59, Issue 5, Pages (May 2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Volume 55, Issue 4, Pages (April 1999)
The Case | Hypertension and neuropathy after travel
Volume 54, Issue 5, Pages (November 1998)
Victoria F. Norwood, Scott G. Morham, Oliver Smithies 
Wilhelm Kriz, Michel Lehir  Kidney International 
Volume 62, Issue 4, Pages (October 2002)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 70, Issue 11, Pages (December 2006)
Volume 70, Issue 10, Pages (November 2006)
Volume 60, Issue 1, Pages (July 2001)
Volume 55, Issue 2, Pages (February 1999)
Volume 66, Issue 3, Pages (September 2004)
Volume 57, Issue 3, Pages (March 2000)
Volume 70, Issue 2, Pages (July 2006)
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Volume 64, Issue 3, Pages (September 2003)
Volume 66, Issue 5, Pages (November 2004)
Volume 68, Issue 1, Pages (July 2005)
Volume 53, Issue 5, Pages (May 1998)
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney  Yee-Yung Ng, Chun-Cheng Hou, Wansheng.
Volume 75, Issue 1, Pages (January 2009)
Volume 62, Issue 3, Pages (September 2002)
Volume 65, Issue 2, Pages (February 2004)
Volume 60, Issue 4, Pages (October 2001)
Volume 66, Issue 4, Pages (October 2004)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 70, Issue 6, Pages (September 2006)
Volume 71, Issue 9, Pages (May 2007)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 56, Issue 5, Pages (November 1999)
Volume 80, Issue 5, Pages (September 2011)
Nephrology in Latin America, with special emphasis on Brazil
Volume 63, Issue 3, Pages (March 2003)
Angiotensin II production and distribution in the kidney – II
Volume 69, Issue 7, Pages (April 2006)
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Endothelial cell activation
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Volume 58, Issue 4, Pages (October 2000)
Prostaglandins in macula densa function
A nest in renal fibrosis?
Volume 73, Issue 5, Pages (March 2008)
Volume 53, Issue 5, Pages (May 1998)
Volume 75, Issue 6, Pages (March 2009)
Volume 62, Issue 3, Pages (September 2002)
Volume 61, Issue 6, Pages (June 2002)
Volume 65, Issue 1, Pages (January 2004)
Presentation transcript:

Volume 64, Issue 6, Pages 2172-2181 (December 2003) Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney  Clarice Kazue Fujihara, Gláucia Rutigliano Antunes, A.N.A. Lúcia Mattar, Natalie Andreoli, Denise Maria Avancini, Costa Malheiros, Irene Lourdes Noronha, Roberto Zatz  Kidney International  Volume 64, Issue 6, Pages 2172-2181 (December 2003) DOI: 10.1046/j.1523-1755.2003.00319.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Parameters of renal injury/inflammation 60days after renal ablation in sham (S) group, sham + celecoxib (S + CEL), renal ablation (Nx), and renal ablation + celecoxib (Nx + CEL). (A) Glomerulosclerosis index (GSI).(B) Fractional cortical interstitial area (%INT). (C) Percent vascular injury (%VASC). (D) Extent of macrophage infiltration (Mφ). *P < 0.05 vs. respective sham group; †P < 0.05 vs. respective untreated group. Kidney International 2003 64, 2172-2181DOI: (10.1046/j.1523-1755.2003.00319.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Cyclooxygenase-2 (COX-2) expression followed four typical patterns in this study (positive cells appear heavily stained). (A) Macula densa staining observed in all groups. (B) Glomerular infiltration by COX-2–positive cells. Note that in this case the infiltration concentrated at a sclerosing area. (C) Interstitial infiltration by COX-2–positive cells, appearing mostly in inflamed areas. (D) Infiltration of arterial/arteriolar walls by COX-2–positive cells, following an “onion skin” pattern. Patterns exemplified in (B, C, and D) appeared only in renal ablation group and, to a lesser extent, in the renal ablation group given celecoxib. Kidney International 2003 64, 2172-2181DOI: (10.1046/j.1523-1755.2003.00319.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Graphic representation of the expression of cyclooxygenase-2 (COX-2) at the macula densa (A), glomeruli (B), interstitial area (C) and arteries/arterioles (D) in the four groups studied.*P < 0.05 vs. respective sham group; †P < 0.05 vs. respective untreated group. Abbreviations are: S, sham group; S + CEL, sham + celecoxib; Nx, renal ablation, and Nx + CEL, renal ablation + celecoxib. Kidney International 2003 64, 2172-2181DOI: (10.1046/j.1523-1755.2003.00319.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Parameters of renal injury represented as a function of cyclooxygenase-2 (COX-2) expression. The extent of injury at the glomeruli, cortical interstitium, and vessels correlated positively and significantly with the respective “ectopic” expression of COX-2, but not with the expression of COX-2 at the macula densa (data not shown). (A) Glomerulosclerosis index (GSI) vs. the intensity of COX-2 staining at the glomerular tuft (expressed as stained cells/100 glomerular profiles). (B) Fraction of the cortical area occupied by interstitial matrix (%INT) vs. the intensity of COX-2 staining at the interstitium (expressed as stained cells/mm2). (C) Percent of arterial/arteriolar profiles exhibiting wall injury (%VASC) vs. intensity of COX-2 staining at the vessels (expressed as stained cells/100 vascular profiles). Kidney International 2003 64, 2172-2181DOI: (10.1046/j.1523-1755.2003.00319.x) Copyright © 2003 International Society of Nephrology Terms and Conditions